Adequate patient selection for coronary revascularization: an overview of current methods used in daily clinical

Steven A J Chamuleau1, Berthe L F van Eck-Smit, Martijn Meuwissen

  • 1Department of Cardiology, Academic Medical Center, University of Amsterdam, The Netherlands. s.a.chamuleau@amc.uva.nl

Insights

Non-invasive stress tests effectively identify coronary artery disease (CAD) and guide risk stratification. Invasive hemodynamic parameters like fractional flow reserve (FFR) accurately assess lesion severity, preventing unnecessary interventions.

Area of Science:

  • Cardiology
  • Diagnostic Imaging
  • Interventional Cardiology

Background:

  • Non-invasive stress modalities (exercise ECG, MPS, stress echocardiography) are primary tools for diagnosing Coronary Artery Disease (CAD).
  • Non-invasive assessment of perfusion abnormalities aids in risk stratification for CAD patients.
  • Stress testing is crucial before cardiac catheterization to confirm myocardial ischemia, a prerequisite for coronary revascularization.

Purpose of the Study:

  • To evaluate the role of invasive hemodynamic parameters (Coronary Flow Velocity Reserve - CFVR, Fractional Flow Reserve - FFR) in assessing functional severity of coronary narrowings.
  • To compare the accuracy of invasive hemodynamic parameters with non-invasive stress tests in CAD assessment.
  • To determine the safety and clinical utility of deferring Percutaneous Transluminal Coronary Angioplasty (PTCA) based on normal CFVR and FFR values.

Main Methods:

  • Utilized invasive hemodynamic parameters, specifically CFVR and FFR, during cardiac catheterization.
  • Compared CFVR and FFR results with established non-invasive stress testing outcomes.
  • Analyzed the application of these indices in 'ad hoc' PTCA settings and for patients with multivessel CAD.

Main Results:

  • FFR and CFVR effectively identify the functional severity of specific coronary lesions, showing good agreement with non-invasive stress test results.
  • Normal FFR and CFVR values support the safety of deferring PTCA procedures.
  • These indices facilitate selective evaluation of coronary narrowings in multivessel CAD, aiding clinical decision-making.

Conclusions:

  • Invasive hemodynamic parameters (FFR, CFVR) provide crucial functional information on coronary stenoses, complementing anatomical data from coronary angiography.
  • Utilizing FFR and CFVR can help avoid unnecessary revascularization procedures, which are costly and carry potential risks.
  • These parameters are valuable tools for guiding therapeutic decisions in CAD management, particularly in 'ad hoc' PTCA and multivessel disease scenarios.

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...